352 related articles for article (PubMed ID: 27533087)
1. Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer.
Efazat G; Novak M; Kaminskyy VO; De Petris L; Kanter L; Juntti T; Bergman P; Zhivotovsky B; Lewensohn R; Hååg P; Viktorsson K
Oncotarget; 2016 Sep; 7(37):60332-60347. PubMed ID: 27533087
[TBL] [Abstract][Full Text] [Related]
2. Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene.
Sukka-Ganesh B; Mohammed KA; Kaye F; Goldberg EP; Nasreen N
BMC Cancer; 2012 Jul; 12():309. PubMed ID: 22824143
[TBL] [Abstract][Full Text] [Related]
3. Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
Ishikawa M; Miyahara R; Sonobe M; Horiuchi M; Mennju T; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Huang CL; Date H
Lung Cancer; 2012 Jun; 76(3):431-8. PubMed ID: 22236865
[TBL] [Abstract][Full Text] [Related]
4. Phosphoproteomic profiling of NSCLC cells reveals that ephrin B3 regulates pro-survival signaling through Akt1-mediated phosphorylation of the EphA2 receptor.
Ståhl S; Branca RM; Efazat G; Ruzzene M; Zhivotovsky B; Lewensohn R; Viktorsson K; Lehtiö J
J Proteome Res; 2011 May; 10(5):2566-78. PubMed ID: 21413766
[TBL] [Abstract][Full Text] [Related]
5. The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.
Wu Y; Du Z; Mou J; Qiu X; Chen J; Cai S; Ren D; Xiao F; Zhou G; Yuan C
Curr Med Chem; 2023; 30(20):2340-2353. PubMed ID: 35996244
[TBL] [Abstract][Full Text] [Related]
6. Eph/ephrin signalling serves a bidirectional role in lipopolysaccharide‑induced intestinal injury.
Xiong Y; Li KX; Wei H; Jiao L; Yu SY; Zeng L
Mol Med Rep; 2018 Aug; 18(2):2171-2181. PubMed ID: 29901151
[TBL] [Abstract][Full Text] [Related]
7. Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase.
Ferluga S; Hantgan R; Goldgur Y; Himanen JP; Nikolov DB; Debinski W
J Biol Chem; 2013 Jun; 288(25):18448-57. PubMed ID: 23661698
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer.
Lee HY; Mohammed KA; Kaye F; Sharma P; Moudgil BM; Clapp WL; Nasreen N
Int J Nanomedicine; 2013; 8():4481-94. PubMed ID: 24293999
[TBL] [Abstract][Full Text] [Related]
9. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC
Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975
[TBL] [Abstract][Full Text] [Related]
10. Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells in vitro and in vivo by inhibiting the EphA2/Akt signaling pathway.
Chen M; Hu C; Guo Y; Jiang R; Jiang H; Zhou Y; Fu H; Wu M; Zhang X
Oncol Rep; 2018 Sep; 40(3):1339-1347. PubMed ID: 29956803
[TBL] [Abstract][Full Text] [Related]
11. EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.
Brantley-Sieders DM; Caughron J; Hicks D; Pozzi A; Ruiz JC; Chen J
J Cell Sci; 2004 Apr; 117(Pt 10):2037-49. PubMed ID: 15054110
[TBL] [Abstract][Full Text] [Related]
12. Ephrin-B3 ligand promotes glioma invasion through activation of Rac1.
Nakada M; Drake KL; Nakada S; Niska JA; Berens ME
Cancer Res; 2006 Sep; 66(17):8492-500. PubMed ID: 16951161
[TBL] [Abstract][Full Text] [Related]
13. Human dendritic cells express neuronal Eph receptor tyrosine kinases: role of EphA2 in regulating adhesion to fibronectin.
de Saint-Vis B; Bouchet C; Gautier G; Valladeau J; Caux C; Garrone P
Blood; 2003 Dec; 102(13):4431-40. PubMed ID: 12907451
[TBL] [Abstract][Full Text] [Related]
14. EphA receptors and ephrin-A ligands are upregulated by monocytic differentiation/maturation and promote cell adhesion and protrusion formation in HL60 monocytes.
Mukai M; Suruga N; Saeki N; Ogawa K
BMC Cell Biol; 2017 Aug; 18(1):28. PubMed ID: 28851287
[TBL] [Abstract][Full Text] [Related]
15. Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder.
Abraham S; Knapp DW; Cheng L; Snyder PW; Mittal SK; Bangari DS; Kinch M; Wu L; Dhariwal J; Mohammed SI
Clin Cancer Res; 2006 Jan; 12(2):353-60. PubMed ID: 16428472
[TBL] [Abstract][Full Text] [Related]
16. Roles of EphA1/A2 and ephrin-A1 in cancer.
Ieguchi K; Maru Y
Cancer Sci; 2019 Mar; 110(3):841-848. PubMed ID: 30657619
[TBL] [Abstract][Full Text] [Related]
17. EphA2/Ephrin-A1 signaling complexes restrict corneal epithelial cell migration.
Kaplan N; Fatima A; Peng H; Bryar PJ; Lavker RM; Getsios S
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):936-45. PubMed ID: 22247486
[TBL] [Abstract][Full Text] [Related]
18. May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?
Psilopatis I; Karniadakis I; Danos KS; Vrettou K; Michaelidou K; Mavridis K; Agelaki S; Theocharis S
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613532
[TBL] [Abstract][Full Text] [Related]
19. Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition.
Lin SY; Lee YX; Yu SL; Chang GC; Chen JJ
Oncotarget; 2016 Apr; 7(16):21799-811. PubMed ID: 26967563
[TBL] [Abstract][Full Text] [Related]
20. p0071 interacts with E-cadherin in the cytoplasm so as to promote the invasion and metastasis of non-small cell lung cancer.
Zhao H; Zhang D; Yang L; Wang E
Mol Carcinog; 2018 Jan; 57(1):89-96. PubMed ID: 28898462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]